ArticleClinical and translational medicine2021

Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer.

Minting Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.